Provided by Tiger Fintech (Singapore) Pte. Ltd.

Incyte

56.80
-1.4100-2.42%
Post-market: 57.450.6500+1.14%17:52 EDT
Volume:2.16M
Turnover:122.49M
Market Cap:10.99B
PE:378.67
High:58.23
Open:57.48
Low:56.13
Close:58.21
Loading ...

Incyte Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
1 hour ago

Incyte Is Maintained at Neutral by JP Morgan

Dow Jones
·
5 hours ago

JPMorgan Adjusts Incyte Price Target to $68 From $70, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

BofA Adjusts Price Target on Incyte to $87 From $86, Keeps Buy Rating

MT Newswires Live
·
17 Apr

Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

StockStory
·
15 Apr

Incyte Corp. Stock Advances 4.1%, Outperforms Competitors

Dow Jones
·
15 Apr

Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
12 Apr

Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
11 Apr

Incyte Faces Limited Exposure From Tariffs on Dual Sourcing, UBS Says

MT Newswires Live
·
11 Apr

Press Release: Incyte to Report First Quarter Financial Results

Dow Jones
·
10 Apr

Sun Pharmaceutical Industries Says U.S. Court Of Appeals Vacates Preliminary Injunction On Leqselvi

Reuters
·
10 Apr

Incyte price target lowered to $61 from $69 at UBS

TIPRANKS
·
09 Apr

Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
09 Apr

AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis

Zacks
·
08 Apr

BRIEF-Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Apr

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Apr

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Apr

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

StockStory
·
07 Apr

Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
05 Apr